SCHEMBL13248348

SCHEMBL13248348

CC(C)c1cn2c(n1)SCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.49
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
GFER P55789 1/20 0.49
KMT2A Q03164 9/20 0.47
MEN1 O00255 8/20 0.47
TP53 P04637 1/20 0.47
GLA P06280 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
LMNA P02545 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
GAA P10253 3/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HSD17B10 Q99714 3/20 0.44
NSD2 O96028 1/20 0.42
ALPL P05186 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339941 0.75
SCHEMBL19185513 0.74 MAPT (0.46) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL16387195 0.71 GFER (0.35) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL13268068 0.70 MAPT (0.56) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL925818 0.67 MAPT (0.47) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL7181038 0.67 MAPT (0.49) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL9743017 0.65 KMT2A (0.65) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL9840784 0.65 MAPT (0.50) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL14490303 0.64 WDR5 (0.48) MAPTNPC1RAB9ASMN1; SMN2GFER
SCHEMBL20320557 0.64 MAPT (0.46) MAPTNPC1RAB9ASMN1; SMN2GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B MAPT 4788/4885NPC1 603/4885RAB9A 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.